Evidence map›Paper›PMID 27499155›Full record

ArticleScientific reports2016

Genetic markers of pigmentation are novel risk loci for uveal melanoma.

Robert Ferguson, Matjaz Vogelsang, Esma Ucisik-Akkaya, Karan Rai, Robert Pilarski, Carlos N Martinez, Justin Rendleman, Esther Kazlow, Khagay Nagdimov, Iman Osman and 5 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Iris Colour and the Risk of Developing Uveal Melanoma.International journal of molecular sciences · 2020
    Review
  17. Review
  18. Article
  19. Large HERCs Function as Tumor Suppressors.Frontiers in oncology · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Robert FergusonPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Matjaz VogelsangPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Esma Ucisik-AkkayaPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Karan RaiDivision of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Robert PilarskiDivision of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Carlos N MartinezPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Justin RendlemanPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Esther KazlowPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Khagay NagdimovPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Iman OsmanPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
Robert J KleinDepartment of Genetic and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
Frederick H DavidorfHavener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University, Columbus, OH USA.
Colleen M CebullaHavener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University, Columbus, OH USA.
Mohamed H Abdel-RahmanDivision of Human Genetics, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.
Tomas KirchhoffPerlmutter Cancer Center, New York University School of Medicine, New York, USA.
New York University · USThe Ohio State University · USEastern Cooperative Oncology Group · USIcahn School of Medicine at Mount Sinai · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The Ohio State University Center for clinical and Translational ScienceUL1TR001070 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2013 to 2017
$22.6M
The Ohio State University Center for Clinical and Translational Science (UL1)UL1TR000090 · NCATS · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA D · 2012 to 2013
$7.9M
Genetic polymorphisms in retinal detachment with proliferative vitreoretinopathyK08EY022672 · NEI · OHIO STATE UNIVERSITY · PI CEBULLA, COLLEEN MARIE · 2012 to 2016
$1.1M
Hereditary cancer predisposition syndromes and uveal melanomaR21CA191943 · NCI · OHIO STATE UNIVERSITY · PI ABDEL-RAHMAN, MOHAMED H. · 2015 to 2016
$368k
NCATS NIH HHS UL1 TR000090NCATS NIH HHS UL1 TR001070NCI NIH HHS P30 CA016058NCI NIH HHS R21 CA191943NEI NIH HHS K08 EY022672
6 · The paper itself

Abstract

While the role of genetic risk factors in the etiology of uveal melanoma (UM) has been strongly suggested, the genetic susceptibility to UM is currently vastly unexplored. Due to shared epidemiological risk factors between cutaneous melanoma (CM) and UM, in this study we have selected 28 SNPs identified as risk variants in previous genome-wide association studies on CM or CM-related host phenotypes (such as pigmentation and eye color) and tested them for association with UM risk. By logistic regression analysis of 272 UM cases and 1782 controls using an additive model, we identified five variants significantly associated with UM risk, all passing adjustment for multiple testing. The three most significantly associated variants rs12913832 (OR = 0.529, 95% CI 0.415-0.673; p = 8.47E-08), rs1129038 (OR = 0.533, 95% CI 0.419-0.678; p = 1.19E-07) and rs916977 (OR = 0.465, 95% CI 0.339-0.637; p = 3.04E-07) are correlated (r(2) > 0.5) and map at 15q12 in the region of HERC2/OCA2, which determines eye-color in the human population. Our data provides first evidence that the genetic factors associated with pigmentation traits are risk loci of UM susceptibility.

Indexed as

Genetic LociPolymorphism, Single NucleotideAdolescentAdultAgedAged, 80 and overBiomarkers, TumorFemaleGenome-Wide Association StudyHumansMaleMelanomaMiddle AgedPigmentationRisk FactorsUveal NeoplasmsBiomarkers, Tumor

Identifiers

PMID27499155
PMCPMC4976361
OpenAlexW2506969860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.